Insomni

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 17, 2009, Pages 1766-1768

  Bjorvatn, Bjørn ^a,b   Sivertsen, Børge ^a   Øyane, Nicolas ^a,b   Nordhus, Inger Hilde ^a,b   Pallesen, Ståle ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLASSIFICATION; HUMAN; INSOMNIA; MEDICAL LEAVE; MENTAL DISEASE; QUALITY OF LIFE; REVIEW; RISK FACTOR;

ADULT; HUMANS; MENTAL DISORDERS; QUALITY OF LIFE; RISK FACTORS; SICK LEAVE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 70349564974     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.08.0379     Document Type: Article

References (28)

1. The international classification of sleep disorders. 2. utg. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
2. Pallesen S, Nordhus IH, Nielsen GH et al. Prevalence of insomnia in the adult Norwegian population. Sleep 2001; 24: 771-9.
3. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6: 97-111.
4. Hohagen F, Rink K, Kappler C et al. Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci 1993; 242: 329-36.
5. Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev 2006; 10: 7-18.
6. Manber R, Edinger JD, Gress JL et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008; 31: 489-95.
7. Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev 2006; 10: 419-29.
8. Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord 2003; 76: 255-9.
9. Zammit GK, Weiner J, Damato N et al. Quality of life in people with insomnia. Sleep 1999; 22 (suppl 2): S379-85.
10. Edinger JD, Means MK, Carney CE et al. Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia. Sleep 2008; 31: 599-607.
11. Backhaus J, Junghanns K, Born J et al. Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release. Biol Psychiatry 2006; 60: 1324-30.
12. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med 2003; 65: 259-67.
13. Sivertsen B, Øverland S, Bjorvatn B et al. Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res 2009; 66: 67-74.
14. Sivertsen B, Øverland S, Neckelmann D et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol 2006; 163: 1018-24.
15. Øverland S, Glozier N, Sivertsen B et al. A comparison of insomnia and depression as predictors of disability pension: the HUNT Study. Sleep 2008; 31: 875-80.
16. Stoller MK. Economic effects of insomnia. Clin Ther 1994; 16: 873-97; discussion 54.
17. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999; 22 (suppl 2): S386-93.
18. Buscemi N, Vandermeer B, Friesen C et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007; 22: 1335-50.
19. Kripke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev 2000; 4: 5-20.
20. Sivertsen B, Omvik S, Pallesen S et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006; 295: 2851-8.
21. Kripke DF, Klauber MR, Wingard DL et al. Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998; 43: 687-93.
22. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151: 1172-80.
23. Morin CM, Colecchi C, Stone J et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281: 991-9.
24. Bjorvatn B. Langvarige søvnvansker - kan de behandles? Tidsskr Nor Lægeforen 2000; 120: 579-82.
25. Omvik S, Sivertsen B, Pallesen S et al. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone. Behav Res Ther 2008; 46: 623-41.
26. Roth T, Costa e Silva JA, Chase MH. Sleep and cognitive (memory) function: research and clinical perspectives. Sleep Med 2001; 2: 379-87.
27. Thorpy MJ. Which clinical conditions are responsible for impaired alertness? Sleep Med 2005; 6 (suppl 1): S13-20.
28. Oxman AD, Flottorp S, Havelsrud K et al. A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PLoS One 2007; 2: e1040.